Table 3.
Imaging tests
| In first DD (n = 138) | Not in first DD (n = 62) | P | |||
|---|---|---|---|---|---|
| First imaging test | |||||
| TTE | 43 | (36.1) | 28 | (50.9) | 0.002* |
| CT | 53 | (44.5) | 16 | (29.1) | – |
| TEE | 18 | (15.1) | 3 | (5.5) | – |
| MRI | 3 | (2.5) | 0 | (0) | – |
| CAG | 1 | (0.8) | 5 | (9.1) | – |
| All imaging tests | |||||
| TTE | 62 | (52.1) | 39 | (70.9) | 0.02 |
| CT | 92 | (77.3) | 37 | (67.3) | 0.16 |
| TEE | 54 | (45.4) | 23 | (42.6) | 0.73 |
| MRI | 6 | (5.0) | 4 | (7.3) | 0.56 |
| CAG | 3 | (2.5) | 10 | (18.2) | <0.001 |
Table compares the first and total number of tests used in patients with and without AD in the first differential diagnosis
*P-value for all categories
TTE transthoracic echocardiography, CT computed tomography, TEE transoesophageal echocardiography, MRI magnetic resonance imaging, CAG coronary angiography